|
T.N. Khalfina, A.N. Maksudova
Сlinical interrelations of arterial hypertension and gout
|
№6 / 2011
|
|
G.P. Arutiunov, L.G. Oganezova, A.V. Sokolova
Assessment of renal function, involvement of renal glomeruli and tubulo-interstitium in patients with arterial hypertension
|
№6 / 2011
|
|
G.P. Arutiunov, A.V. Sokolova, L.G. Oganesova
Experimental models of renal tubulointersitial damade in arterial hypertension
|
№2 / 2011
|
|
О.V. Rtyscheva, O.F. Kalev
Structural remodeling of myocardium in patients with arterial hypertension, receiving chronic haemodyalisis
|
№2 / 2011
|
|
G.P. Arutiunov, L.G. Oganesova
Renal tubulointerstium and it’s involvement in arterial hypertension
|
№1 / 2011
|
|
M.G. Gallyamov, M.M. Severova, O.A. Surkova
Development of early stages of chronic kidney disease in patients with obesity
|
№6 / 2010
|
|
M.L. Nanchikeeva, L.V. Kozlovskaya
Nephroprotecive and cardioprotective effects of angiotensin-converting enzyme inhibitor in patients with hypertensive nephropathy
|
№6 / 2010
|
|
V.V. Fomin, V.V. Panasiuk
Frequent pitfalls in antihypertensive therapy
|
№5 / 2010
|
|
M.L. Maximov
Angiotensin II receptor blocker valsartan and angiotensin-converting enzyme inhibitor enalapril in hypertensive patients with renal transpalant nephropathy
|
№5 / 2010
|
|
L.V. Podorolskaya, E.L. Tchumakova, L.V. Lobanova, L.A. Alexeeva
Fibrinolytic activity of the urine in patients with arterial hypertension with different efficacy of antihypertensive treatment
|
№5 / 2010
|
|
E.A. Saginova, A.D. Aksiutin, T.N. Krasnova, V.V. Fomin, N.A. Moukhin
Peculiarities of IgA-nephropathy clinical course, associated with excess body mass weight
|
№5 / 2010
|
|
I.E. Chazova, V.V. Fomin
European Society of Hypertension Guidelines 2009: what is changed?
|
№4 / 2010
|
Русский
